arrow_back Back to App

Improved Access to Innovative Medical Devices for Kidney Disease Patients

This act aims to enhance access to new, innovative medical devices for individuals with end-stage renal disease (ESRD) covered by Medicare. It introduces temporary, additional payments for healthcare providers, encouraging the use of newer technologies in diagnosing and treating this condition. As a result, patients may benefit from more modern treatment methods, potentially improving their quality of life and reducing hospitalizations.
Key points
Establishes a temporary, three-year add-on payment for new FDA-approved medical devices used in the diagnosis, treatment, or management of end-stage renal disease (ESRD).
Aims to increase the availability of innovative technologies for Medicare patients with ESRD, potentially improving their treatment and reducing healthcare costs.
The additional payments are designed to incentivize the adoption and use of newer devices that could shorten hospital stays and improve patient outcomes.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5331
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Process start date: 2021-09-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Patient Access to ESRD New Innovative Devices Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5331.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-09-22.

What are the main provisions?

Key points include:

  • Establishes a temporary, three-year add-on payment for new FDA-approved medical devices used in the diagnosis, treatment, or management of end-stage renal disease (ESRD).
  • Aims to increase the availability of innovative technologies for Medicare patients with ESRD, potentially improving their treatment and reducing healthcare costs.
  • The additional payments are designed to incentivize the adoption and use of newer devices that could shorten hospital stays and improve patient outcomes.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Danny K. [D-IL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health Benefits